positive - no capital needed for another year unless maybe commercial requirements.
downside.
first unitract gets canned
now seems like unifill is no longer the main game - alan said we are not getting the big deal - so how do unilife reach there volumes forecast in 2015/16 and beyond.
its ok saying that they have higher margin pumps / infusers - but why not do it all.
sanofi seem nowhere in sight and its going to be a slow and steady climb
UNS Price at posting:
53.0¢ Sentiment: Buy Disclosure: Held